Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H46N.Cl |
Molecular Weight | 396.092 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1
InChI
InChIKey=SXPWTBGAZSPLHA-UHFFFAOYSA-M
InChI=1S/C25H46N.ClH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(2,3)24-25-21-18-17-19-22-25;/h17-19,21-22H,4-16,20,23-24H2,1-3H3;1H/q+1;/p-1
Molecular Formula | C25H46N |
Molecular Weight | 360.6394 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Cetalkonium chloride is a cationic quaternary ammonium surfactant, which is used for the treatment of mouth ulcers and sores (Bonjela trade name). It is also serves as an excipient for the purpose of long-term stabilization of ciclosporin ocular formulation, used in patients with dry eye syndrom (Ikervis trade name). The antibacterial properties of cetalkonium can be explained by its detergent character. Once applied, cetalkonium blocks the survival of biofilm forming bacterias.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | BONJELA Approved UseFor the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices. |
|||
Inactive ingredient | IKERVIS Approved UseTreatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes. Launch Date2015 |
|||
Primary | BONJELA Approved UseFor the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices. |
Doses
Dose | Population | Adverse events |
---|---|---|
0.1 % 1 times / day single, topical Studied dose Dose: 0.1 %, 1 times / day Route: topical Route: single Dose: 0.1 %, 1 times / day Sources: |
healthy, 28 to 55 years Health Status: healthy Age Group: 28 to 55 years Sex: M+F Sources: |
Other AEs: Contact dermatitis... |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Contact dermatitis | 37.5% | 0.1 % 1 times / day single, topical Studied dose Dose: 0.1 %, 1 times / day Route: topical Route: single Dose: 0.1 %, 1 times / day Sources: |
healthy, 28 to 55 years Health Status: healthy Age Group: 28 to 55 years Sex: M+F Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Detection of cationic surfactants in oral rinses and a disinfectant formulation using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | 2001 |
|
Exciplex-type behavior and partition of 3-substituted indole derivatives in reverse micelles made with benzylhexadecyldimethylammonium chloride, water and benzene. | 2001 Feb |
|
Occupational allergic contact dermatitis from alkylammonium amidobenzoate. | 2001 May-Jun |
|
The trouble with teething--misdiagnosis and misuse of a topical medicament. | 2002 May |
|
Sulfentrazone adsorbed on micelle-montmorillonite complexes for slow release in soil. | 2003 May 21 |
|
Investigation of the effects of wall adsorption of the visualization agent on baseline noise characteristics for indirect UV detection in capillary electrophoresis. | 2003 Sep |
|
Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models. | 2004 Apr |
|
Static and dynamic light-scattering studies on micellar solutions of alkyldimethylbenzylammonium chlorides. | 2004 Aug 15 |
|
The synaptic vesicle proteome: a comparative study in membrane protein identification. | 2004 Oct |
|
Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis. | 2005 Dec |
|
Resonance Rayleigh scattering study of interaction of heparin with some cationic surfactants and their analytical application. | 2005 Mar |
|
Enrichment of integral membrane proteins from small amounts of brain tissue. | 2006 Aug |
|
Mass spectrometrical identification of brain proteins including highly insoluble and transmembrane proteins. | 2006 Aug |
|
Equilibrium studies for the adsorption of acid dye onto modified hectorite. | 2006 Aug 25 |
|
Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques. | 2006 Dec |
|
Condensed film formation of binary mixtures of cetyltrimethylammonium bromide and cetyldimethylbenzylammonium chloride in a wide potential region at the mercury/electrolyte interface. | 2006 Dec 1 |
|
A new multiphasic buffer system for benzyldimethyl-n-hexadecylammonium chloride polyacrylamide gel electrophoresis of proteins providing efficient stacking. | 2006 Feb |
|
Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model. | 2006 Feb 17 |
|
Water remediation by micelle-clay system: case study for tetracycline and sulfonamide antibiotics. | 2006 Jul |
|
Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes. | 2006 Mar 27 |
|
Resonance Rayleigh scattering method for the determination of cationic surfactants with chromium(VI)-iodide system. | 2006 May |
|
Dechlorination of beta-methylallyl chloride by electrogenerated [Co(I)(bipyridine)3]+: an electrochemical study in the presence of cationic surfactants. | 2006 May 15 |
|
Synaptic vesicle proteins under conditions of rest and activation: analysis by 2-D difference gel electrophoresis. | 2006 Sep |
|
Visual determination of nitrite and nitrate in waters by color band formation method. | 2006 Sep |
|
Comparative study of the photophysical behavior of fisetin in homogeneous media and in anionic and cationic reverse micelles media. | 2007 May-Jun |
|
Evaluation of two proteomics technologies used to screen the membrane proteomes of wild-type Corynebacterium glutamicum and an L-lysine-producing strain. | 2007 Oct |
|
Two-dimensional separation of membrane proteins by 16-BAC-SDS-PAGE. | 2009 |
|
16-BAC/SDS-PAGE analysis of membrane proteins of yeast mitochondria purified by free flow electrophoresis. | 2009 |
|
Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay. | 2009 Aug 25 |
|
Characterization of multifunctional reverse micelles' interfaces using hemicyanines as molecular probes. II: Effect of the surfactant. | 2009 May 14 |
|
Modulation of excited-state proton-transfer reactions of 7-hydroxy-4-methylcoumarin in ionic and nonionic reverse micelles. | 2009 May 14 |
|
On the formation of new reverse micelles: a comparative study of benzene/surfactants/ionic liquids systems using UV-visible absorption spectroscopy and dynamic light scattering. | 2009 Sep 15 |
|
Sorption of quaternary ammonium compounds to municipal sludge. | 2010 Apr |
|
Highlights on the capacities of "Gel-based" proteomics. | 2010 Apr 28 |
|
Cationic reverse micelles create water with super hydrogen-bond-donor capacity for enzymatic catalysis: hydrolysis of 2-naphthyl acetate by alpha-chymotrypsin. | 2010 Aug 2 |
|
Adsorptive removal of cationic surfactants from aqueous solutions onto high-area activated carbon cloth monitored by in situ UV spectroscopy. | 2010 Feb 15 |
|
[Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy]. | 2010 Jun |
|
Ammonium detection by formation of colored zebra-bands in a detecting tube. | 2010 Jun 15 |
|
Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. | 2013 Aug |
Patents
Sample Use Guides
Massage one centimetre of the topical formulation (Bonjela) onto the affected area (mouth ulcers and sores) and leave at least 30 min in case of denture sores. In dry eye disease, the recommended dose is one drop of the ocular formulation (Ikervis) once daily to be applied to the affected eye(s) at bedtime.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24001405
Corneal human cells were treated with 0.005% cetalkonium chloride cationic oil-inwater nanoemulsion for 30 min. The emulsion was able to increase the pace of healing, as measured by the reduction of the size of the scraped area.
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:32:14 GMT 2025
by
admin
on
Wed Apr 02 08:32:14 GMT 2025
|
Record UNII |
85474O1N9D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
69108
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082068
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
32942
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
31202
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
Cetalkonium chloride
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
3078
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
122-18-9
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
m3286
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID3041665
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
C77034
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
85474O1N9D
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
SUB07445MIG
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
204-526-3
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
C012817
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
DBSALT001776
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
85474O1N9D
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL1624075
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
1843
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
47907
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |